Becton, Dickinson and Company (BDX) is listed on NYSE in Medical Device Stocks. It is $189.57, +0.77%, with a $51.6B market cap. RSI is 74.2, overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 74.2 Overbought
Market Cap $51.6B
P/E Ratio 119.2x
Volume 1.7M
Fundamentals — 10-Q Q3 2026
Revenue $14.2B
Net Income $449.0M
EPS $1.59
Gross Margin 46.0%
Operating Margin 8.6%
Net Margin 3.2%
Debt / Equity 0.6x
P/E Ratio 119.2x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Feld Michael | EVP, Chief Revenue Officer | Sell | 165 | $188.49 | $31,101 | 2026 Aug 26 |
| Polen Thomas E JR | Chairman, CEO and President | Sell | 4,152 | $185.00 | $768,120 | 2026 Aug 13 |
| Goette Roland | EVP and President, EMEA | Sell | 2,438 | $180.84 | $440,888 | 2026 Aug 11 |
| Feld Michael | EVP, Chief Revenue Officer | Sell | 75 | $157.13 | $11,785 | 2026 Jul 27 |
| Feld Michael | EVP, Chief Revenue Officer | Sell | 75 | $152.80 | $11,460 | 2026 Jun 26 |
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sell | 1,100 | $145.66 | $160,226 | 2026 Jun 24 |
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sell | 1,100 | $151.48 | $166,628 | 2026 Jun 10 |
| Polen Thomas E JR | Chairman, CEO and President | Sell | 2,764 | $146.35 | $404,511 | 2026 Jun 1 |
| Feld Michael | EVP, Chief Revenue Officer | Sell | 75 | $147.35 | $11,051 | 2026 May 26 |
| Feld Michael | EVP, Chief Revenue Officer | Sell | 74 | $151.94 | $11,244 | 2026 Apr 27 |
| Feld Michael | EVP, Chief Revenue Officer | Sell | 75 | $156.83 | $11,762 | 2026 Mar 26 |
| Feld Michael | EVP, Chief Revenue Officer | Sell | 75 | $181.84 | $13,638 | 2026 Feb 26 |
| Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 74 | $196.08 | $14,510 | 2025 Dec 26 |
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sell | 629 | $196.03 | $123,303 | 2025 Dec 17 |
| Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 75 | $193.36 | $14,502 | 2025 Dec 1 |
| Scott Bertram L | Director | Sell | 217 | $176.58 | $38,318 | 2025 Nov 7 |
| Feld Michael | EVP & President, Life Sciences | Sell | 57 | $186.01 | $10,603 | 2025 Oct 27 |
| Feld Michael | EVP & President, Life Sciences | Sell | 58 | $181.03 | $10,500 | 2025 Sep 26 |
| Fraser Claire | Director | Sell | 917 | $187.50 | $171,938 | 2025 Sep 10 |
| Feld Michael | EVP & President, Life Sciences | Sell | 57 | $197.99 | $11,285 | 2025 Aug 22 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $71.72 | 56.2 | $32.6B |
| | $90.82 | 63.9 | $34.3B |
| | $145.15 | 42.3 | $10.1B |
| | $90.19 | 55.1 | $52.0B |
| | $554.74 | 47.7 | $43.7B |
Take BDX further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put BDX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Becton, Dickinson and Company next reports.
Set alerts on BDX
Get notified when Becton, Dickinson and Company hits your price targets or technical conditions are met.
Get Started Free